Возраст домена | 25 лет |
Дата окончания | Истек срок регистрации |
PR | 6 |
ИКС | 0 |
Страниц в Google | 923 |
Страниц в Яндексе | 160 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 3137044 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
We’re advancing the clinical application of immune tolerance. | Immune Tolerance Network
immune tolerance, tolerance, immunology, drug development, immune system, clinical trials, diabetes, transplantation, islet transplantation, autoimmune, autoimmunity, allergy, asthma, research, funding, support
n/a
UTF-8
43.38 КБ
429
3 657 симв.
3 157 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
nih.gov | 83 | 8 |
0 | 113 | 65 | |
wikipedia.org | 49 | 9 |
0 | 5 | 6 | |
medscape.com | 29 | 7 |
0 | 2705 | 1296 | |
webmd.com | 24 | 7 |
0 | 552 | 197 | |
youtube.com | 20 | 9 |
0 | 2 | 2 | |
nature.com | 19 | 9 |
0 | 740 | 269 | |
mayoclinic.org | 18 | 7 |
0 | 832 | 297 | |
thefreedictionary.com | 16 | 7 |
0 | 610 | 638 | |
sciencedaily.com | 13 | 8 |
0 | 3875 | 1533 | |
wiley.com | 11 | 8 |
2000 | 405 | 206 | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 16 Мая 2014 ) | |
Количество ссылок на сайт | 293 |
Количество доменов, которые ссылаются на сайт | 81 |
Количество найденных анкоров | 26 |
Исходящие (внешние) ссылки домена | 144 |
Количество доменов, на которые ссылается сайт | 30 |
Количество исходящих анкоров | 17 |
Внешние ссылки главной страницы ( 3 ) | |
itntrialshare.org | TRIALSHAREAccess raw data, analysis and clinical specimens |
bravos-study.org/ | BRAVOS is a clincial trial evaluating Brentuximab Vendotin treatment for Diffuse Cutaneous Systemic Sclerosis. |
niaid.nih.gov/ | National Institute of Allergy and Infectious Diseases |
Внутренние ссылки главной страницы ( 61 ) | |
/ | Home |
/about | About Us |
/professionals/about-us/our-mission-values | Mission & Values |
/professionals/about-us/people | Leadership |
/news | View All |
/about-us/careers | Careers |
/professionals/about-us/partner-itn | Partnerships |
/professionals/about-us/our-sponsors | Sponsors |
/about-us/achievements | Achievements |
/researchers-0 | Clinical Trials |
/researchers/clinical-trials/allergy-asthma | Allergy & Asthma |
/researchers/clinical-trials/autoimmune-disease | Autoimmune Disease |
/researchers/clinical-trials/transplantation | Transplantation |
/researchers/clinical-trials/type-1-diabetes | Type 1 Diabetes |
/professionals/research/core-facilities | Core Facilities |
/professionals/research/lab-protocols | Lab Protocols |
/professionals/research/itn-protocols | ITN Protocols |
/professionals/research/t1d-preclinical-consortium | T1D Preclinical Consortium |
/researchers/policies | Policies |
/researchers/policies/publications-policy | Publications Policy |
/researchers/proposals | Proposals |
/researchers/proposals/submit-proposal | Submit Proposal |
researchers/proposals/current-rfps | REQUEST FOR PROPOSALClinical trials of desensitization in solid organ transplantation |
/researchers/proposals/past-rfps | Past RFPs |
/professionals/research/publications | Publications |
/researchers/trialshare | TrialShare |
immunetolerance.org/researchers/strategic-plans | Immune Tolerance NetworkSTRATEGIC PLANS |
/researchers/strategic-plans/allergy | Allergy |
/researchers/strategic-plans/autoimmune-disease | Autoimmune Disease |
/researchers/strategic-plans/transplantation | Transplantation |
/researchers/strategic-plans/type-1-diabetes | Type 1 Diabetes |
/public/clinical-trial-info/active-trials | For Patients |
patients/clinical-trial-information/allergy-asthma | Allergy & Asthma Allergy & Asthma ITN is focused on achieving durable desensitization to allergen exposure |
/patients/autoimmune-disease | Autoimmune Disease |
/patients/transplantation | Transplantation |
/public/transplantation/kidney | Kidney |
/public/transplantation/liver | Liver |
patients/clinical-trial-information/type-1-diabetes | Type 1 Diabetes Type 1 Diabetes ITN's trials aim to identify therapies that preserve beta cell function |
/public/clinical-trial-info | Clinical Trial Info |
/trialshare | TrialShare |
/contact-us | Contact |
/contact/contact-us | Contact |
/contact/contact-us/bri-seattle-office | BRI - Seattle Office |
/contact/contact-us/mgh-bethesda-office | MGH - Bethesda Office |
/contact/contact-us/ucsf-san-francisco-office | UCSF - San Francisco Office |
/contact/contact-us/media-inquiries | Media Inquiries |
members.immunetolerance.org/ | Member Portal |
/professionals/about-us | More |
public/autoimmune-disease | Autoimmune Disease Autoimmune Disease ITN is identifying therapies to achieve durable clinical remission of autoimmune dis... |
public/transplantation | Transplantation Transplantation ITN's goal is to induce tolerance of transplanted organs without lifelong immunosuppressio... |
immunetolerance.org/studies/TEACH?view=patients | TEACH: Investigating a treatment to allow kidney transplant recipients to stop immunosuppressive medications. |
immunetolerance.org/studies/ACTIVATE?view=patients | The ACTIVATE Study will look at how the type of delivery may protect, or put a baby at risk, for allergies. |
/professionals/research/clinical-trials | All Clinical Trials |
/news/2019/08/itns-leap-study-continues-influence-dietary-gu... | ITN’s LEAP Study Continues to Influence Dietary Guidance for Infants as well as Product Development |
/news/2019/08/strong-association-between-malt1-locus-and-pea... | A Strong Association Between MALT1 Locus and Peanut Allergy |
/news/2019/08/activate-study-investigating-microbiome-exposu... | ACTIVATE Study Investigating Microbiome Exposure in C-section Infants and Allergy Development Begins Recruitment |
/news/2019/08/itn-vitiligo-clinical-trial-news | ITN Vitiligo Clinical Trial in the News |
/search | Search |
/privacy | Privacy |
/terms-use | Terms of Use |
/accessibility | Accessibility |
Domain Name:IMMUNETOLERANCE.ORG
Domain ID: D9013738-LROR
Creation Date: 1999-08-11T19:40:50Z
Updated Date: 2014-06-06T18:16:58Z
Registry Expiry Date: 2015-08-11T19:40:39Z
Sponsoring Registrar:Network Solutions, LLC (R63-LROR)
Sponsoring Registrar IANA ID: 2
WHOIS Server:
Referral URL:
Domain Status: clientTransferProhibited
Registrant ID:807532-NSI
Registrant Name:Immune Tolerance Network
Registrant Organization:Immune Tolerance Network
Registrant Street: 185 Berry St. Suite 3509
Registrant City:SAN FRANCISCO
Registrant State/Province:CA
Registrant Postal Code:94107
Registrant Country:US
Registrant Phone:+1.4152780706
Registrant Phone Ext:
Registrant Fax: +1.4152780708
Registrant Fax Ext:
Registrant Email:tvo@diabetes.ucsf.edu
Admin ID:807579-NSI
Admin Name:Aaron Gannon
Admin Organization:UCSF Immune Tolerance Network
Admin Street: 185 Berry Street, Suite 3509
Admin City:San Francisco
Admin State/Province:CA
Admin Postal Code:94107
Admin Country:US
Admin Phone:+1.2063426553
Admin Phone Ext:
Admin Fax: +1.4152780708
Admin Fax Ext:
Admin Email:tech@immunetolerance.org
Tech ID:45940293-NSI
Tech Name:Gary Kuyat
Tech Organization:UCSF Immune Tolerance Network
Tech Street: 185 Berry St.
Tech City:San Francisco
Tech State/Province:CA
Tech Postal Code:94107
Tech Country:US
Tech Phone:+1.4157044566
Tech Phone Ext:
Tech Fax:
Tech Fax Ext:
Tech Email:gkuyat@immunetolerance.org
Name Server:UDNS1.ULTRADNS.NET
Name Server:UDNS2.ULTRADNS.NET
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to(a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.
США - 208.215.179.146
John Wiley & Sons
Verizon Business
HTTP/1.0 200 OK
Date: Wed, 25 Dec 2019 19:01:18 GMT
Server: Apache/2.4.18 (Ubuntu)
Cache-Control: must-revalidate, no-cache, private
X-Drupal-Dynamic-Cache: MISS
Link: ; rel="shortlink", ; rel="canonical"
Link: ; rel="revision"
X-UA-Compatible: IE=edge
Content-language: en
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
expires: -1
Vary: Accept-Encoding
X-Generator: Drupal 8 (https://www.drupal.org)
X-Drupal-Cache: HIT
pragma: no-cache
Connection: close
Content-Type: text/html; charset=UTF-8
Set-Cookie: BIGipServerpl_www.immunetolerance.org_443=1409602570.47873.0000; path=/; Httponly; Secure
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"